Paracetamol in Pregnancy: Unraveling the Autism and ADHD Debate
Is paracetamol safe during pregnancy? This question has sparked heated debates among experts and policymakers, leaving expectant mothers confused and concerned. A recent comprehensive review, published in the British Medical Journal (BMJ), aims to settle the controversy surrounding prenatal paracetamol (acetaminophen) use and its potential link to autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD) in children.
Conflicting Expert Opinions: In a notable incident, the U.S. president advised against Tylenol (acetaminophen) use during pregnancy in September 2025, citing autism risk. This statement contradicted the stance of medical authorities and health agencies worldwide, who maintain that paracetamol is safe for pregnant women. But here's where it gets controversial—the BMJ review reveals that the evidence is not as clear-cut as it seems.
The Evidence Unraveled: The review analyzed existing studies linking maternal paracetamol use during pregnancy to ADHD and ASD in children. While some studies suggest a connection, the review highlights significant flaws in their methodology and potential biases. These studies often fail to account for crucial factors like maternal health, genetics, and family environment, which are essential when determining causal relationships.
Study Selection and Evaluation: Researchers meticulously searched major databases, including Embase, Medline, Cochrane, PsycINFO, Epistemonikos, and grey literature sources, to gather systematic reviews and meta-analyses. They identified nine systematic reviews, including four meta-analyses, that met the stringent inclusion criteria. These reviews primarily focused on maternal paracetamol use throughout pregnancy, with only one considering both antenatal and postnatal exposure.
Methodological Shortcomings: The quality assessment exposed methodological weaknesses in most reviews. Many lacked registered protocols, comprehensive search strategies, and justifications for excluding studies. Risk of bias assessments was often incomplete or missing, and standardized tools were not utilized. These limitations significantly impact the reliability of the findings.
Findings: A Complex Picture: All reviews reported positive associations between prenatal paracetamol exposure and neurodevelopmental disorders, but the strength of these associations varied. Longer or third-trimester exposure seemed to increase the risk. However, when accounting for shared familial and genetic factors, these associations diminished. This suggests that the observed relationships may not be due to the drug itself but rather to other confounding variables.
Interpreting the Results: The BMJ review concludes that the current evidence does not establish a clear causal link between prenatal paracetamol exposure and ADHD or ASD. The apparent associations in whole-cohort studies are likely influenced by familial or unmeasured factors, not the drug's direct effect. This finding aligns with the stance of medical authorities, emphasizing the need for rigorous methodology in research.
Implications and Future Research: This review highlights the importance of high-quality research in informing public health decisions. While paracetamol is generally considered safe during pregnancy, the study underscores the need for further investigation to fully understand its potential long-term effects. The debate also prompts a broader discussion on the challenges of interpreting conflicting scientific evidence and the role of policymakers in communicating health risks to the public.
Journal Reference:
Sheikh J, Allotey J, Sobhy S, et al. (2025). Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention-deficit/hyperactivity disorder in offspring: an umbrella review of systematic reviews. BMJ, 391, e088141. DOI: 10.1136/bmj-2025-088141, https://www.bmj.com/content/391/bmj-2025-088141
What do you think about the conflicting evidence and expert opinions surrounding paracetamol use during pregnancy? Should policymakers make health recommendations based on limited evidence, or is it better to wait for more conclusive research? Share your thoughts in the comments below!
